Martin R. Brown
Directeur Général chez Ambra Bioscience LLC
Profil
Martin R.
Brown is the founder of Ambra Bioscience LLC, which is founded in 2010, where he holds the title of Chief Executive Officer.
He previously worked as a Director of Information Systems at Eli Lilly & Co., Director at Equinox Center, Senior Vice President of Human Resources at Amylin Pharmaceuticals, Inc., and Media Contacts Relations, SVP-Finance & Operations at Elcelyx Therapeutics, Inc. Mr. Brown received his undergraduate degree and MBA from Drexel University.
Postes actifs de Martin R. Brown
| Sociétés | Poste | Début |
|---|---|---|
Ambra Bioscience LLC
 Ambra Bioscience LLC BiotechnologyHealth Technology Ambra Bioscience LLC operates as a research and development biotechnology company. It offers Lovidia a dietary supplement. The company was founded by Martin Brown and William Trebasky in March 2010 and is headquartered in San Diego, CA. | Directeur Général | 01/01/2010 |
Anciens postes connus de Martin R. Brown
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Responsable des Ressources Humaines | - |
| Equinox Center | Directeur/Membre du Conseil | - |
Elcelyx Therapeutics, Inc.
 Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elcelyx Therapeutics, Inc. develops novel therapeutics based on gut sensory modulation. Its product NewMet is being developed for use by type 2 diabetes patients who have difficulty tolerating generic metformin or are contraindicated for its use. The firm also provides dietary supplements for weight management. The company was founded by Alain D. Baron in 2010 and is headquartered in San Diego, CA. | Directeur Financier/CFO | - |
Formation de Martin R. Brown
| Drexel University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Entreprise privées | 4 |
|---|---|
Elcelyx Therapeutics, Inc.
Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elcelyx Therapeutics, Inc. develops novel therapeutics based on gut sensory modulation. Its product NewMet is being developed for use by type 2 diabetes patients who have difficulty tolerating generic metformin or are contraindicated for its use. The firm also provides dietary supplements for weight management. The company was founded by Alain D. Baron in 2010 and is headquartered in San Diego, CA. | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
| Equinox Center | |
Ambra Bioscience LLC
Ambra Bioscience LLC BiotechnologyHealth Technology Ambra Bioscience LLC operates as a research and development biotechnology company. It offers Lovidia a dietary supplement. The company was founded by Martin Brown and William Trebasky in March 2010 and is headquartered in San Diego, CA. | Health Technology |
